| Ytd | 0.07% | |
| 1y | 13.28% |
| Open | 13.34 | Prev Close | 13.78 | Low | 13.22 | High | 13.79 | Mkt Cap | 463.10M |
| Vol | 53.38K | Avg Vol | 105.70K | EPS | -1.14 | P/E | -11.82 | Forward P/E | -1.23 |
| Beta | 0.88 | Short Ratio | 1.35 | Inst. Own | 82.59% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-14 | 50-d Avg | 12.16 | 200-d Avg | 12.29 | 1yr Est | 25.43 |
Top Wall Street analysts changed outlook on top names. See all rating changes on analyst ratings pag
Late-breaking abstract for BB-301 presented at the Muscular Dystrophy Association (MDA) Clinical and
- Interim clinical results for the BB-301 Phase 1b/2a study include 12-month post-treatment follow-u
HAYWARD, Calif., March 10, 2026 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec”
-Interim clinical study results for the BB-301 Phase 1b/2a Treatment Study including 12-month follow
Benitec Biopharma: BB-301's Early OPMD Data And Cash Infusion Justify A Bullish Upgrade
• Patient 1 of Cohort 1 has now completed the 24-month follow-up timepoint, and at month-24 post-tre
Benitec Biopharma Limited (NASDAQ: BNTC - Get Free Report) Director Suvretta Capital Management, L b
Benitec Biopharma Limited (NASDAQ: BNTC - Get Free Report) Director Suvretta Capital Management, L p
The average of price targets set by Wall Street analysts indicates a potential upside of 83.9% in Be
Benitec Biopharma Limited (NASDAQ: BNTC - Get Free Report) Director Suvretta Capital Management, L b
The mean of analysts' price targets for Benitec Biopharma (BNTC) points to an 87.5% upside in the st
Benitec Biopharma (BNTC) has become technically an oversold stock now, which implies exhaustion of t
– Fast Track Designation was granted for BB-301 following U.S. Food and Drug Administration (FDA) re
In the past week or so, beneficial owners Carl Icahn and Mario Gabelli made some big bets in Monro I
HAYWARD, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (Nasdaq: BNTC) (“Benitec”
HAYWARD, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (Nasdaq: BNTC) (“Benitec”
HAYWARD, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec”
Investor webcast to be held on Monday November 3, 2025 at 8:00 am EST Investor webcast to be held on
Benitec Biopharma Limited (NASDAQ: BNTC - Get Free Report) has been assigned an average rating of "M
Interim Clinical Study Results for Cohort 1 of the BB-301 Phase 1b/2a Treatment Study Anticipated in
During Tuesday's trading, 188 companies set new 52-week lows.
On Monday, 413 companies reached new 52-week lows.
New Equities that Broke Through 52-Week Lows Friday Morning During Friday's morning session, 12
During Wednesday's trading, 517 companies set new 52-week lows.
On Monday, 429 stocks made new 52-week lows.
During Friday's session, 574 stocks hit new 52-week lows.
On Tuesday, 126 companies set new 52-week lows.
Gainers Digital Media Solutions, Inc. (NYSE: DMS) shares climbed 71.9% to close at $2.20 on Frida
On Wednesday, 297 companies achieved new lows for the year.
Gainers Missfresh Limited (NASDAQ: MF) shares rose 112.9% to $0.2450 in pre-market trading after
Gainers USA Truck, Inc. (NASDAQ: USAK) shares climbed 112.6% to close at $31.00 on Friday. DB Sc
Gainers USA Truck, Inc. (NASDAQ: USAK) shares jumped 111% to $30.76. DB Schenker and USA Truck a
On Thursday, 216 stocks hit new 52-week lows.
On Tuesday, 951 companies hit new 52-week lows.
During Monday's trading, 1214 companies set new 52-week lows.
On Wednesday, 216 stocks hit new 52-week lows.
During Thursday, 351 stocks hit new 52-week lows.
Tuesday's session saw 211 companies set new 52-week lows.
Gainers AMC Entertainment Holdings, Inc. (NYSE: AMC) shares surged 23.7% to close at $12.77. Mo
Gainers HighPoint Resources Corporation (NYSE: HPR) shares jumped 118.8% to close at $10.83 on We
Stocks Which Set New 52-Week Low Yesterday, Tues., Dec. 20, 2018
Stocks Which Set New 52-Week Low The Last Trading Session, Fri., Dec. 7, 2018
41 Biggest Movers From Yesterday
15 Biggest Mid-Day Gainers For Tuesday